China made another breakthrough in battling the coronavirus pandemic, with China National Biotec Group (CNBG) announcing Wednesday that an inactivated COVID-19 vaccine production workshop of its affiliated Beijing institute of biological products, the first and largest of its kind in the world, has passed national examination.

The facility was granted a production certificate and it is now available for use, CNBG, an affiliate of the state-run China National Pharmaceutical Group, said in a statement sent to the Global Times.